OMER · Company research
Omeros Corporation (OMER): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
22records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Understanding Momentum Shifts in (OMER) - Stock Traders Daily | Understanding Momentum Shifts in (OMER) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 17, 2026 | neutral | 0 | 0.6 |
| Omeros Corporation - Common Stock (Nasdaq:OMER) Stock Quote - FinancialContent | Omeros Corporation - Common Stock (Nasdaq:OMER) Stock Quote FinancialContent | View source ↗ | FinancialContent | Oct 16, 2026 | neutral | 0 | 0.6 |
| Omeros Stock Price Forecast. Should You Buy OMER? - StockInvest.us | Omeros Stock Price Forecast. Should You Buy OMER? StockInvest.us | View source ↗ | StockInvest.us | Oct 16, 2026 | neutral | 0 | 0.6 |
| H.C. Wainwright Maintains Buy on Omeros (OMER) Despite Regulatory Setback, Stock Drops 14% - GuruFocus | H.C. Wainwright Maintains Buy on Omeros (OMER) Despite Regulatory Setback, Stock Drops 14% GuruFocus | View source ↗ | GuruFocus | Oct 16, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 16, 2026 | neutral | 0 | 0.6 |
| $OMER stock is down 13% today. Here's what we see in our data. - Quiver Quantitative | $OMER stock is down 13% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 16, 2026 | neutral | 0 | 0.6 |
| Omeros shares slide following European regulatory setback for Narsoplimab - Yahoo Finance | Omeros shares slide following European regulatory setback for Narsoplimab Yahoo Finance | View source ↗ | Yahoo Finance | Oct 16, 2026 | neutral | 0 | 0.6 |
| Omeros Faces Second Rejection Of Narsoplimab In Europe – OMER Stock Falls Below Key Support For First Time In Nearly 3 Months - TradingView | Omeros Faces Second Rejection Of Narsoplimab In Europe – OMER Stock Falls Below Key Support For First Time In Nearly 3 Months TradingView | View source ↗ | TradingView | Oct 16, 2026 | neutral | 0 | 0.6 |
| OMER Stock Tests Key Support After Second European Rejection For Narsoplimab - Stocktwits | OMER Stock Tests Key Support After Second European Rejection For Narsoplimab Stocktwits | View source ↗ | Stocktwits | Oct 16, 2026 | neutral | 0 | 0.6 |
| A U.S.-approved drug for a transplant complication gets a negative opinion from Europe's medicines panel. - Stock Titan | A U.S.-approved drug for a transplant complication gets a negative opinion from Europe's medicines panel. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights - Stocktwits | AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits | OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism Stocktwits | View source ↗ | Stocktwits | Oct 12, 2026 | neutral | 0 | 0.6 |
| OMER Stock Gains 4% — CMS Green-Lights $287K Add-On Payments For Transplant Drug - Stocktwits | OMER Stock Gains 4% — CMS Green-Lights $287K Add-On Payments For Transplant Drug Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Omeros (OMER) Stock Looks Cheap After Its Huge Three Year Run - Simply Wall Street | Omeros (OMER) Stock Looks Cheap After Its Huge Three Year Run Simply Wall Street | View source ↗ | Simply Wall Street | Oct 2, 2026 | neutral | 0 | 0.6 |
| What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now? - Yahoo Finance | What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 28, 2026 | neutral | 0 | 0.6 |
| Insider Sale: VP of $OMER Sells 10,000 Shares | OMER Stock News - Quiver Quantitative | Insider Sale: VP of $OMER Sells 10,000 Shares | OMER Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 25, 2026 | neutral | 0 | 0.6 |
| Omeros Corp (OMER) director lines up fresh stock sale - Stock Titan | Omeros Corp (OMER) director lines up fresh stock sale Stock Titan | View source ↗ | Stock Titan | Aug 20, 2026 | neutral | 0 | 0.6 |
| Omeros (OMER) Stock Jumps On YARTEMLEA Profit Breakthrough - Simply Wall Street | Omeros (OMER) Stock Jumps On YARTEMLEA Profit Breakthrough Simply Wall Street | View source ↗ | Simply Wall Street | Aug 13, 2026 | neutral | 0 | 0.6 |
| OMER Stock Soars 24% After-Hours On YARTEMLEA Sales Momentum, Debt Reduction And Share Buybacks - TradingView | OMER Stock Soars 24% After-Hours On YARTEMLEA Sales Momentum, Debt Reduction And Share Buybacks TradingView | View source ↗ | TradingView | Aug 12, 2026 | neutral | 0 | 0.6 |
| Omeros will discuss Q2 results in an Aug. 12 webcast - Stock Titan | Omeros will discuss Q2 results in an Aug. 12 webcast Stock Titan | View source ↗ | Stock Titan | Aug 10, 2026 | neutral | 0 | 0.6 |
| Is Omeros Corporation (OMER) the Best Get Rich Quick Stock to Buy Right Now? - Yahoo Finance | Is Omeros Corporation (OMER) the Best Get Rich Quick Stock to Buy Right Now? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 6, 2026 | neutral | 0 | 0.6 |
| $OMER stock is down 16% today. Here's what we see in our data. | OMER Stock News - Quiver Quantitative | $OMER stock is down 16% today. Here's what we see in our data. | OMER Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 12, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.